Investment hedging guide: The latest German clinical study shows that Pfizer’s mRNA vaccine may cause autoimmune hepatitis, Yongan Futures’ first-quarter net profit fell by 90.1% year-on-year, and Raycus’ first-quarter net profit fell by 81% year-on-year

Key Data Concepts:   

? These are the company names, stock quotes, topics, and entities related to this data.

000157 000581 000615 000698 000739 001965 002075 002353 002600 002645 002740 002791 002793 002900 300115 300205 300207 300498 300509 300631 300747 Anyuan Coal Industry Group Apeloa Pharmaceutical Apple Flavor & Fragrance Group China Merchants Expressway Network & Technology Holdings Deppon Logistics Fujian Ideal Jewellery Industrial Guangdong Kinlong Hardware Products Haitong Securities Huaneng Power International Jiangsu Huahong Technology Stock Jiangsu Shagang Kinghand Industrial Investment Group Lingyi Itech (Guangdong) Company Liuzhou Liangmianzhen Nanjing Securities Qinghai Huading Industrial Shanghai Film Corporation Shanghai Fosun Pharmaceutical Shanghai Mechanical & Electrical Industry Shenyang Chemical Industry Triangle Tyre Weifu High-Technology Group Will Semiconductor Shanghai Yantai Jereh Oilfield Services Group Zoomlion Heavy Industry Science And Technology Science, Technology Society Shareholder Research, Development Pharmaceutical Hardware Coal Securities University Cancer Medicine Technology, Engineering Athletics, Track, Field

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets

Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!

Already have an account?
Login

Home » News » Investment hedging guide: The latest German clinical study shows that Pfizer’s mRNA vaccine may cause autoimmune hepatitis, Yongan Futures’ first-quarter net profit fell by 90.1% year-on-year, and Raycus’ first-quarter net profit fell by 81% year-on-year